Focused Ultrasound Might Help Alzheimer’s Drugs Get Into the Brain Faster, Shows Potential in Enhanced Treatment of Neurodegenerative Disorders

Medicine & Technology Apr 08, 2024

A study has found that sound waves can safely be targeted at selected regions of the brain to open a protective barrier and enable Alzheimer’s medications to be more effective. Check this article to learn more.

Incidence of Parkinson’s Disease in the US is 50% Higher Than Thought

Dec 16, 2022

Incidence rates of neurodegenerative disorder Parkinson's Disease is actually higher than perceived. Read to know more about this condition and its rising incidence.

Alzheimer Treatment Breakthrough: Blood Oxygen Levels’ Link to Memory Loss Helps Study to Prevent Syndrome

May 29, 2021

In a world-first discovery, researchers have observed how blood oxygen levels in the brain affect memory loss, a precursor to the development of Alzheimer's disease.

Scientists Report That There Are Four Types of Alzheimer's, What Are They?

May 03, 2021

A new study reports that there's not only one, but four different types of the progressive brain disorder.

Dementia, Not Daydreaming: Child Diagnosed With Rare Disease

Oct 10, 2020

What was previously thought as daydreaming turned out to be a form of "childhood dementia" as a four-year-old girl in England was diagnosed with a rare, fatal disease.

Astrocytes Found Responsible for Nerve Cell Death in Glaucoma

Jun 24, 2020

A new study reveals that astrocytes, the star-shaped glial cells in the CNS, play an essential role in the death of nerve cells in degenerative diseases. The researchers did trials on mice to study the effects of the cell in preventing nerve damage.

Alcohol Lowers Risk Of Death In People With Alzheimer's, Study Suggests

Dec 13, 2015

A current study suggests that risk of premature death in people suffering from Alzheimer's disease can be lowered with moderate consumption of alcohol.

$7.5 Million Grant Awarded To Start Clinical Trial For Alzheimer’s

Sep 16, 2015

The National Institute of Health awarded an estimated $7.5 million grant to Johns Hopkins University to fund the ongoing clinical trials for Alzheimer’s disease drug.